Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/2781
Title: | Recombinant FSH versus hMG in Controlled Ovarian Stimulation for IVF |
Authors: | Supriyadi, Agus Harzif, Achmad K. Jaidy, Wael O. Al |
Keywords: | controlled ovarian stimulation hMG infertility in vitro fertilization rFSH |
Issue Date: | Oct-2021 |
Abstract: | Recombinant FSH versus hMG in Controlled Ovarian Stimulation for IVF Follicle Stimulating Hormone rekombinan dibandingkan hMG pada stimulasi ovarium terkontrol untuk Fertilisasi in Vitro Agus Supriyadi, Achmad K. Harzif, Wael O. Al Jaidy Department of Obstetrics and Gynecology Faculty of Medicine Universitas Indonesia Dr. Cipto Mangunkusumo General Hospital Jakarta Abstract Abstrak Objective: To investigate the relationship between gonadotropins which are used in the process of controlled ovarian stimulation, rFSH and hMG, and the in vitro fertilization outcomes, which are oocyte number, embryo number, and fertilization rate during the period of 2013 to 2019. Tujuan: Mengetahui hubungan stimulasi ovarium terkendali yang mendapatkan sediaan gonadotropin berupa rFSH dan hMG dengan luaran FIV berupa jumlah oosit, jumlah embrio, dan tingkat pembuahan pada periode 2013– 2019. Metode: Penelitian ini menggunakan desain potong lintang menggunakan data rekam medis yang menjalani program FIV di Klinik Melati Harapan Kita tahun 2013 – 2019. Data yang digunakan adalah data pasien yang menjalani program dengan protokol rFSH dan hMG dibandingkan dengan luaran jumlah oosit, tingkat pembuahan, dan jumlah embrio. Methods: This research was a cross sectional study. Data from medical record of patients who underwent the in vitro fertilization procedure at Melati Clinic, Harapan Kita Child and Mother Hospital were obtained. This research collected the oocyte number, embryo number, and fertilization rate of eligible patients who received rFSH or hMG stimulation. Hasil: Dari 454 pasien yang memenuhi kriteria, 309 pasien menggunakan rFSH sebagai obat stimulasi ovarium dan 145 pasien menggunakan hMG sebagai obat stimulasi ovarium. Hasil uji non parametrik lebih tinggi pada kelompok pengguna rFSH dengan ketiga variabel yang diteliti ditemukan bermakna secara signifikan dengan hasil p < 0,05. Result: Four hundred and fifty four patients were eligible for the research, further divided into 309 patients who received rFSH and 145 patients who received hMG. Non-parametric test revealed that patients who belong to the rFSH group had a statistically significant higher oocyte number, embryo number, and fertilization rate compared to hMG group with p < 0.05. Kesimpulan: Terdapat perbedaan yang signifikan antara jumlah oosit, fertilization rate, dan jumlah embrio pada kelompok rFSH dan hMG (P < 0,05) dengan rata-rata oosit, tingkat pembuahan, dan jumlah embrio kelompok rFSH lebih besar daripada kelompok hMG. Conclusions: Significant difference of oocyte number, embryo number, and fertilization rate exists between rFSH and hMG group (p < 0.05) with the mean oocyte number, embryo number, and fertilization rate are consistently observed higher in the rFSH group compared to hMG group. Kata kunci: hMG, infertilitas, fertilisasi in vitro, rFSH, stimulasi ovarium. Keywords: controlled ovarian stimulation, hMG, infertility, in vitro fertilization, rFSH. |
URI: | http://localhost:8080/xmlui/handle/123456789/2781 |
Appears in Collections: | 1. Indonesian Journal Of Obstetrics and Gynecology (INAJOG) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
192-197.pdf | 87.94 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.